Sun Pharma Advanced Research Company Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

32.45

27.19

26.21

26.21

25.09

Share application money

-

234.26

-

-

1.11

Preference share capital

-

-

-

-

-

Reserves & surplus

480.32

-230.22

-194.46

-44.84

270.03

Loan funds

Secured loans

0.05

75.00

196.72

67.80

1.09

Unsecured loans

-

-

-

-

-

Total

512.83

106.23

28.46

49.16

297.33

Uses of funds

Fixed assets

Gross block

145.41

132.55

122.12

135.33

80.15

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

39.66

40.68

31.56

31.46

22.60

Net block

105.75

91.87

90.56

103.86

57.56

Capital work-in-progress

27.00

26.37

5.23

32.07

24.13

Investments

290.90

11.66

6.43

8.49

210.58

Net current assets

Current assets, loans & advances

406.48

150.18

127.47

128.14

106.22

Less : current liabilities & provisions

317.30

173.86

201.23

223.40

101.15

Total net current assets

89.18

-23.67

-73.75

-95.26

5.07

Miscellaneous expenses not written

-

-

-

-

-

Total

512.83

106.23

28.46

49.16

297.33

Notes:

Book value of unquoted investments

290.90

11.66

6.43

8.49

210.58

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

84.97

167.13

95.28

95.62

109.02

Number of equity sharesoutstanding (Lacs)

3245.22

2718.79

2620.48

2620.48

2509.36